$XWEL Balance Sheet | Understand Stock

$XWEL

$0.75 +$0.07 (10.48%) Close

$XWEL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Contract Assets
Inventory
Other current assets
Total current assets
Restricted cash
Property and equipment, net
Intangible assets, net
Operating lease right-of-use assets, net
Goodwill
Security deposits
Other assets
Total assets
Current liabilities
Accounts payable, accrued expenses and other
Accounts payable
Accrued expenses and other current liabilities
Accrued Series G convertible preferred stock redemption payable
Current portion of operating lease liabilities
Current portion of promissory note, unsecured
Deferred revenue
Convertible senior secured note, net
Total current liabilities

Long-term liabilities
Warrant liabilities
Derivative liability
Operating lease liabilities
Total liabilities
Temporary equity
Series G Convertible Preferred Stock, $0.01 par value per share and $1,000 stated value per share, 4,000 shares authorized; 0 and 196 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Liquidation preference of $0 as of June 30, 2026
Equity (deficit)
Common stock, $0.01 par value per share, 150,000,000 shares authorized; 8,471,766 and 6,071,324 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Treasury stock, at cost; 1,338,404 and 0 shares as of June 30, 2022 and December 31, 2021, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total equity (deficit) attributable to XWELL, Inc.

Noncontrolling interests
Total equity (deficit)
Total liabilities, temporary equity and equity

Comments